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ABSTRACT

Parelaphostrongylus tenuis is a parasitic nematode common among deer, elk,
moose, and horses. The parasites attack the central nervous system, laying their eggs in
meningeal tissue resulting in high morbidity and mortality. Techniques currently
available for the most accurate diagnosis include necropsy to detect adult worms in the
brain and spinal cord. The goal of the present research was to develop a way to accurately
diagnose P. tenuis infection antemortem. A gene encoding a P. tenuis protein was
inserted into an expression plasmid and propagated in E. coli. The recombinant protein
was affinity purified, separated on SDS-PAGE gels and transferred to nitrocellulose.
Western blots were utilized to identify anti-P. tenuis antibody present in blood, serum
and spinal fluid using sera from known positive and negative animals. Enzyme
conjugated anti-cervid antibody produced in chickens was used to detect serologically
positive elk, moose and deer. After western blots were confirmed to be effective
diagnostics, enzyme-linked immunosorbent assays (ELISAs) were used to test
overlapping 10-mer synthetic peptides for the development of a more cost effective, less
labor-intensive test. However, due to inconsistent results and cross reactivity with other
similar organisms, we have moved our attention to a full genomic analysis of P. tenuis to
further distinguish a more definitive antigen. This effort is ongoing but is expected to
identify epitopes that are unique to P. tenuis and serve as a useful diagnostic assay.
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CHAPTER ONE
INTRODUCTION AND GENERAL INFORMATION
Introduction to Parelaphostrongylus tenuis
Parelaphostrongylus tenuis is a parasitic nematode in the protostrongylid family
that is often referred to as brain worm or meningeal worm. It is a long, threadlike worm
that can be found in the meninges of white-tailed deer (Odocoileus virginianus). Worms
are found in the veins and venous sinuses of the cranial meninges as well as free in the
cranial subdural space of its definitive host, white-tailed deer where it usually causes little
to no disease state.
P. tenuis possesses a complex life cycle where it infects two distinct hosts. P.
tenuis adults can be found in the deer’s meningeal tissue within the veins and venous
sinuses. Females lay unembryonated eggs that travel via venous blood to the lungs where
they hatch into the first larval stage (L1). L1s then migrate to the alveolar airspace, move
up the trachea, are swallowed, and excreted on the surface of fecal pellets after passing
unharmed through the digestive tract (Anderson 1963).
A variety of terrestrial gastropods, such as snails or slugs, serve as intermediate
hosts (Anderson and Prestwood 1981). They ingest the larva in the excrement or that has
been dispersed into the soil. The nematode matures to the infective third larval stage (L3)
within the foot tissue of the gastropod. Maturation in the intermediate host takes about
four weeks at temperatures between 18° C and 30° C (Anderson 1963). L3s can endure
freezing temperatures, enabling them to overwinter in the intermediate host and are
1

thought to remain infective for the entirety of the intermediate host’s life (Lankester and
Anderson 1968).
P. tenuis infects white-tailed deer upon accidental ingestion of a gastropod while
grazing, thus, completing the cycle. L3s released from the gastropod’s tissues will
penetrate the abomasal wall and enter the peritoneal cavity (Anderson 1963, Anderson
and Strelive 1967). They then are thought to migrate directly to the spinal cord
(Anderson and Strelive 1967). The worms leave the spinal cord via dorsal nerve roots
and move towards the cranium in the spinal subdural space (Anderson 1968).

Significance of Disease
In accidental hosts such as moose and elk, P. tenuis does not migrate to the
appropriate meningeal tissue and instead colonizes the nervous tissue in both the brain
and spinal cord. This causes significant neurological damage to the animal by both
mechanical injury as well as inflammation. Partially due to this aberrant migration, the
nematode is unable to complete its life cycle in these atypical, dead-end hosts.
Unfortunately, the most reliable diagnosis of P. tenuis in aberrant hosts entails a
necropsy in which worms are observed in the brain or spinal cord. Fecal tests such as the
Baermann test are not viable as moose and elk do not reliably shed larvae in their feces.
Additionally, presumptive diagnosis based on presenting neurological symptoms is also
not always reliable. The lack of definitive diagnostics has caused the prevalence of this
disease to be difficult to assess and properly treat.

2

Basis of Research Towards Antemortem Diagnosis
To combat the limitations of current diagnostics, research performed by Duffy,
MacAfee et al. (2002) suggests that atypical hosts could be serologically diagnosed by
enzyme-linked immunosorbent assay (ELISA) for antibodies that are produced in
response to the aspartyl protease inhibitor, Pt-API-1. Additionally, studies performed by
Ogunremi et al. suggest serological diagnosis of P. tenuis involving the development of
an ELISA that utilizes the unique 37-kDa antigen present in P. tenuis show significant
promise (Ogunremi, Lankester et al. 1999b). However, neither of these tests are
commercially available.
Cross reactivity, however, is something that is not well discussed in this research
and needs further investigation not only regarding Pt-API-1, but also any antigen
considered for serological diagnosis. The efficacy of this antigen in serological testing
and potential for cross-reactivity will be addressed in this thesis.
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CHAPTER TWO
LITERATURE REVIEW
Clinical Signs in the Definitive Host
Signs of illness due to infection are rare in the definitive host. Experimental
doses of three-hundred L3 stage larvae given to a fawn showed no clinical signs except
for a loss of guard hairs. Upon necropsy, sixty-five adult P. tenuis nematodes were
recovered (Pybus, Samuel et al. 1989). Another study in which white-tailed deer were
experimentally infected with two-hundred L3 larvae disclosed no clinical signs
throughout the experiment (Anderson 1968).
A couple of accounts have indicated, however, that illness in white-tailed deer is
possible in some circumstances. An enormous number of worms were recovered from a
pregnant, three-year old doe with an unsteady gait, head tilt, and moderate nystagmus. In
this case, eighty adult P. tenuis were recovered from the subdural space as well as an
estimated twenty to thirty worms within the sinuses (Prestwood 1970). Another case
involved a male white-tailed deer which had been experimentally infected with
Haemonchus contortus larvae for a study. The animal began showing signs of ataxia and
started passing P. tenuis larvae in its feces twelve days after the start of the experiment.
The animal died at day sixteen of the experiment and ten live adult P. tenuis were
collected at necropsy from the subdural space. Significant subarachnoid and subcortical
curvilinear hemorrhages were observed over the cerebrum as it appeared the parasite had
invaded these spaces (Eckroade, Zu Rhein et al. 1970).
4

These cases of significant clinical disease in white-tailed deer are not the norm.
For the most part, mature worms will be found in the epidural space or only partially
imbedded in the dura (Anderson 1963). It is in these locations that they are least invasive
and induce minimal inflammation in the definitive host.

Prevalence and Intensity in the Definitive Host
Dependent on geographical location, most white-tailed deer are infected with P.
tenuis at some point in their life. A study done by Karns (1967) found that forty-nine
percent of one-hundred forty deer in Minnesota examined were infected with P. tenuis.
In central Minnesota, where population density of the host was greatest, prevalence was
significantly higher than the lower density regions, suggesting prevalence of infection is
host density dependent. Similarly, Behrend (1968) showed that eighty-four percent of
one-hundred ninety six white-tailed deer in all counties of Maine contained adult
nematodes and places with high density of white-tailed deer had higher incidences of
infection. Other studies, however, indicate that density of host populations does not
increase incidence of infection and therefore had no significant correlation (Gilbert 1973,
Bogaczyk, Krohn et al. 1993).
Underestimations of prevalence is thought to be a significant problem with this
parasite and could account for the disagreement about the correlation between deer
density and incidence of infection. Underestimations, in part, are due to the nature of
definitive diagnosis. Worms within venous sinuses are easily missed during necropsy,
especially if the head is damaged to the point that it cannot be properly examined. Fecal
examination for prevalence is also often misleading as evidence shows that adult white5

tailed deer acquire few additional worms after their first or second summer, creating the
possibility of non-productive unisex infections (Slomke, Lankester et al. 1995).
Similarly, A study done Duffy, Greaves et al. (2002) suggests that infection is also longterm with the possibility of long latent periods. This highlights the necessity for an
antemortem diagnosis for P. tenuis other than fecal exam to identify non-patent infections
and avoid introducing infected animals to non-endemic areas.
In one study performed by Comer et al. (1991) prevalence in the southeastern
United States was studied. P. tenuis was found commonly within the white-tailed deer
of Arkansas, Kentucky, Louisiana, Maryland, North Carolina, Tennessee, Virginia, and
West Virginia as well as the norther portions of Alabama and Georgia. In this study,
95% of the time the worm was found within the first five deer examined. No infected
deer were found in Florida since the discovery of a single worm in 1968.

Impact and Prevalence on Atypical Hosts
In atypical or aberrant host, P. tenuis causes significant clinical disease. Severity
of infection in atypical hosts is thought to be multifactorial. The proportion of worms
that reach the central nervous system is higher and longer development in the spinal cord
results in a larger size and coiling behavior. Additionally, they frequently invade the
ependymal canal (Anderson 1968).
P. tenuis is the causative agent of “moose sickness,” a neurologic disorder by
locomotor dysfunction, fearlessness, circling, weakness, impaired vision, deafness, headtilt, and paraplegia (Anderson 1964). Disease is apparent in moose with as little as one
6

infecting worm (Lankester 2001). Peterson (1989) reported the presence of abnormal
antlers and kidney stones in moose displaying signs of parelaphostrongylosis.
Occasionally, it is possible for moose to show little to no clinical signs during infections
(Gilbert 1974, Thomas and Dodds 1988), making it feasible for moose to coexist with
deer in endemic regions.
Experimental inoculation of moose has shown that large doses of two-hundred L3
larvae given to moose calves at 1 month prove fatal with debilitating neurological signs.
These large doses result in heavy infections with up to forty-one worms recovered from
the central nervous system of one animal (Anderson 1964). These doses, however, are
not realistic as the intermediate host rarely carriers more than a few L3 larvae with an
overall prevalence in gastropods being only 0.01% to 0.8% where moose and white-tailed
deer coexist (Lankester 2001). Lankester (2002) performed an experiment in which a
low dose of three to ten L3 larvae were given to moose calves. Each calf developed
neurological signs twenty to twenty-eight days post inoculation, but all had recovered by
day one-hundred thirty-one. A second, larger dose of fifteen worms was then
administered to the calves and no clinical signs developed. Positive control calves that
were given the larger dose initially developed non-resolving neurological signs and had
to be euthanized. This indicated that low doses in moose can elicit a degree of immune
protection against future infection and implicates a possibility of vaccine development in
atypical hosts.
Moose sickness is theorized to be a contributing factor to moose decline, but little
is certain about its impact. Since, the disease first described in 1932 (Wallace, Thomas et
7

al. 1932), nearly five-hundred cases had been reported in the literature by 1994.
Furthermore, moose populations tend to decrease with the increased population density of
white-tailed deer and incidence of infection (Whitlaw and Lankester 1994). As expected,
the incidence of disease in moose has positive correlation with white-tailed deer
populations (Gilbert 1974, Dumont and Crete 1996). Research has shown that moose
populations can persist in P. tenuis endemic regions as long as the white-tailed deer
population remains below 6/km2 (Whitlaw and Lankester 1994).
While moose sickness has been widely reported, few studies provide estimates of
P. tenuis in moose populations. Over a four-year period in Maine, 80% of one-hundred
fifty-three moose that were showing clinical signs were diagnosed with
parelaphostrongylosis at necropsy. Additionally 25% killed by poachers and 10% to 15%
killed by vehicles or other miscellaneous accidents were infected (Gilbert 1974).
Minnesota also has reported P. tenuis prevalence in cervids. Fifty-four carcasses
of moose that died of unknown causes or were euthanized due to perceived illness
between 2003 and 2013 were submitted for necropsy along with eight moose that had
died from vehicular accidents between 2009 and 2013. Signs of neural migration
attributed to P. tenuis was found in 45% of these moose (Wuenschmann, Armien et al.
2015).
Reintroduced elk in Tennessee’s Cumberland Mountains from Alberta have also
suffered mortality due to P. tenuis infection (Kindall et al., 2011). Of the 62 mortalities,
26 were unable to be determined. However, of the remaining 36 cases, 5 were attributed
to disease caused by P. tenuis. They also predicted an additional 5 deaths with P. tenuis
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as a contributing factor. At this time, the threat of meningeal worm to elk may play a role
in the failure of sustained reintroduction to this region.
Parelaphostrongylosis is also a significant problem in domestic animals such as
llamas, sheep, goats, and alpacas and causes monetary loss to farmers. It is also a
concern for zoos and game farms and fear of spreading the disease has led to restrictions
on the translocation white-tailed deer (Lankester 2001).

Population Distribution of Hosts and Their Interactions
Prior to the early 1900s, moose and deer populations had little overlap and
therefore, the two species had limited interactions and potential for transmission of
diseases (Peterson 1955). The expansion of white-tailed deer into moose ranges is
attributed to logging in the early 1900s (Anderson 1972). An increase in deer population
has led to a decline in moose numbers in these overlapping areas as well as many moose
in these areas presenting with moose sickness (Anderson and Lankester 1974). With
nothing more than anecdotal and opportunistic sightings of sick animals, it’s difficult to
accurately estimate the impact of the disease on the moose population.
Population overlap has also caused issues in other cervid species. In the eastern
United States, P. tenuis is one of the most common diseases in restored elk (Raskevitz,
Kocan et al. 1991). In 2011, the Missouri Department of Conservation began efforts to
restore elk in southern Missouri and later research found through necropsy that up to 33%
of mortality could be attributed to meningeal worm (Chitwood, Keller et al. 2018).
http://www.jwildlifedis.org/doi/abs/10.7589/0090-3558-27.2.348?code=wdas-site
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Diagnosis of Parelaphostrongylosis
Presently, the only way to definitively diagnose P. tenuis, is the recovery of adult
worms from the central nervous system of infected animals or detection by PCR of neural
tissue. This is made difficult by the skill and care it takes to located worms within the
venous sinuses and the fact that a single worm can cause devastating neurological effects
in an atypical host. Clinical signs in susceptible species that are thought to have been in
contact with white-tailed deer or the gastropod intermediate host are suggestive of
parelaphostrongylosis and is the only antemortem diagnostic employed by veterinarians.
Fecal diagnostics for both the definitive host and aberrant hosts have significant
limitations. The traditional fecal examination using the Baerman technique may only
recover a fraction of the larvae present and has poor repeatability. Up to 67% of the
larvae may remained lodged on the sloping surface of the glass, severely
underrepresenting the true larval load (Forrester and Lankester 1997). Furthermore, P.
tenuis is one of the many dorsal-spined larvae found in cervid feces and the morphology
of these closely related species is very similar, (Pybus and Shave 1984). Also, in the
case of unisexual infection, deer would not pass larvae at all. Conversely, false positive
diagnosis has also been shown to be a risk of fecal tests. Duffy, Keppie et al. (1999)
demonstrated that stage-one larvae ingested by rats pass through the alimentary tract
unharmed. This suggests the possibility of susceptible hosts accidentally ingesting larvae
at this stage and uninfected hosts passing larvae and misdiagnosed as positive,
reinforcing the need for a diagnostic that accurately reflects the host’s infection status.
10

Limitations are even more pronounced in aberrant hosts such as moose and elk.
Welch, Pybus et al. (1991) found that most infected elk in their study shed meningeal
worm larvae intermittently and at low densities if they did so at all. In moose, a study by
Karns (1977) showed that only 29% of moose diagnosed as sick were passing larvae.
Additionally, moose frequently pass Parelaphostrongylus andersoni and
Elaphostrongylus rangiferi in their feces. These are similar species of nematodes with
dorsal-spined larvae that cannot be reliably differentiated morphologically from P. tenuis
(Lankester and Fong 1998). Differentiation of these larvae can, however, be
accomplished by polymerase chain reaction (PCR) (Gajadhar, Steeves-Gurnsey et al.,
2000).
Blood chemistry and hematology are often used in conjunction with the presence
of clinical signs to diagnose parelaphostrongylosis. In an endemic area, llamas had been
diagnosed based on clinical signs and eosinophilic pleocytosis (Lunn and Hinchcliff
1989). Two llamas in another study were experimentally infected with P. tenuis, one
with forty-eight worms and the other with six. Each developed clinical signs along with
cerebrospinal fluid (CSF) eosinophilia (Foreyt, Rickard et al. 1991). Furthermore, a study
by Pinn, Bender et al. (2013) investigated the accuracy of CSF eosinophil percentage in
the diagnosis of parelaphostrongylosis. It was found that more than 17% of eosinophils
in CSF had a sensitivity of 85% and specificity of 92% for P. tenuis infection.
However, it is important to note that previous research by Rickard, Smith et al.
(1994) have shown that experimental infections yielded no abnormal blood chemistries.
Additionally, Dew, Bowman et al. (1992) asserts similar doubts exists for this diagnostic
11

in goats as well as white-tailed deer which argues that there is some degree of variability
in these numbers.
Many of the issues with fecal diagnosis and blood chemistry can be overcome
using molecular techniques. Gajadhar, Steeves-Gurnsey et al. (2000), has made progress
with the creation of a PCR to diagnose and differentiate between the morphologically
similar dorsal-spined larvae of the protostrongylid subfamily, Elaphostrongylinae. The
designed primers selectively amplify DNA of the internal transcribed spacer 2 (ITS-2)
region between 5.8S and 28S ribosomal genes. This can differentiate between larvae of
the Elaphostrongylus and Parelaphostrongylus genera based on fragment size.
Additionally, one primer set in a single PCR assay was successfully able to differentiate
between species within the genera Parelaphostrongylus: P. tenuis, P. odocoilei, and P.
andersoni.

Serological Diagnosis of Parelaphostrongylus tenuis
Focus has since shifted to a serological diagnosis using immunological and
molecular techniques. Finding that blood chemistry offered little support in diagnosis of
parelaphostrongylosis, Dew, Bowman et al. (1992) demonstrated the presence of
antibodies in serum and CSF of two goats to antigen extracts of adult P. tenuis using an
enzyme-linked immunosorbent assay (ELISA). They also demonstrated antibodies in
two white-tailed fawns, but only in the CSF. Not long after, Duffy, Tanner et al. (1993)
used similar techniques to detect serum antibodies in fawns, both experimentally and
naturally infected.
12

Neumann, Pon et al. (1994) immunized rabbits with P. tenuis soluble extracts and
identified nine somatic antigens via immunoblot using the acquired rabbit-anti-P. tenuis
immunoglobulin G (IgG). Two of these antigens belonged to the infective third-stage
larvae and measured 25-30 kD and 13 kD. The remaining seven were adult somatic
antigens, four measuring 170-120 kD, two 55 kD, and another 13 kD antigen. These
antigens distinguished P. tenuis from two other closely related nematodes, Dictylocaulus
viviparus and Trichinella spiralis. It was later found by Bienek, Neumann et al. (1998)
that elk experimentally given large doses of P. tenuis recognized both larval and adult
antigens, but small doses only elicited a response to larval antigens. Further experiments
demonstrated elk with adult worms in the central nervous system recognized 25-27 kD,
28-30 kD, and 34-36 larval antigens, but none of these were consistently recognized at
the more realistic, lower doses. Unfortunately, however, these experiments also called
attention to anti-P. tenuis antibodies displaying cross-reactivity with D. viviparus
antigens, despite Neumann’s previous findings.
Ogunremi, Lankester et al. (1999a) evaluated excretory-secretory and somatic
worm antigens for use in serodiagnosis of experimental P. tenuis infections of whitetailed deer. The three antigen preparations explored were the excretory-secretory
products of third-stage larvae (ES-L3), the somatic antigens of third-stage larvae (sL3),
and the somatic antigens of the adults stage (sA). The larval antigens (ES-L3 and sL3)
were both consistently present and reliable for the early detection of P. tenuis while no
anti-sA IgG was ever detected. Unfortunately, cross-reactivity continued to be an issue
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and all three antigen preparations had significant cross reactivity with related parasites,
namely P. andersoni, E. rangiferi, and E. cervi.
It was at this point that an unique 37-kD antigen present in all three antigen
preparations was identified (Ogunremi, Lankester et al. 1999b). Serum from infected
white-tailed deer reacted with five distinct third-stage larval antigens of 105-kD, 45-kD,
37-kD, 32-kD, and 19-kD, but only the 37-kD antigen did not cross react with serum
from caribou infected with P. andersoni and E. rangiferi. It is possible that this antigen
is the same as the 36-kD antigen isolated previously by Neumann, Pon et al. (1994).
Since then, experiments using the excretory secretory products of third-stage larvae for
immunological diagnosis has shown promise in both moose and elk (Ogunremi,
Lankester et al. 2002).
Not long after expressing the need for an antemortem serological diagnosis for P.
tenuis due to false positives in fecal samples and the establishment of the nematode as a
long-lived parasite in white-tailed deer, Duffy and Burt (2002) began investigating the
excretory-secretory antigens of adult P. tenuis for immunodiagnostics. A single 42-43kD protein was consistently recognized by sera of red deer infected with members of the
elaphostrongyline family, P. tenuis, P. andersoni, or E. cervi, but not recognized by
control deer infected with V. sagittatus, a related protostrongylid. The need for a
specific, P. tenuis immunodiagnostic utilizing adult antigens, however, was still evident.

14

Discovery of an Aspartyl Protease Inhibitor
Using mRNA from adult P. tenuis, Duffy, MacAfee et al. (2002) constructed a
cDNA library to identify proteins of potential significance. The library was screened
with sera from infected red deer and immunized Albino Oxford (AO) rats, a protein was
found that, after a BLASTp search, resembled aspartyl protease inhibitors from several
other parasitic nematodes, namely Onchocerca volvulus, Ostertagia ostertagi,
Caenorhabditis elegans, Dirofilaria immitis, and Acanthocheilonema viteae. To deduce a
full-length reading frame, consensus nucleotide sequences from orthologous expressed
sequence tags of Ascaris suum, Brugia malayi, and Parastrongloides tricosuri were used.
An additional orthologue from Ascaris suum was then identified by a BLASTp search
that showed 19% identity to P. tenuis. Highest consensus in sequence identity was with
an orthologue from a similar nematode, Ostertagia ostertagi, at 74%. This gene was
dubbed Pt-API-1 with a predicted mass of the mature protein of approximately 23.4-kD.
The native protein was identified in excretory-secretory products by affinitypurified deer antibodies to rPt-API-1. They bound to a protein of 27-kD. Rat anti-rPtAPI-1 antibodies also bound to a 27-kD protein when probed with HRP-conjugated goat
anti-rat IgG on a Western blot. Additionally, pooled sera from infected red deer and rat
antibodies to excretory-secretory antigens also bound to a 27-kD antigen assumed to be
Pt-API-1, implicating a role of this protein in interaction with the host. The mass of the
protein was estimated to be 33-kD when resolved under reducing conditions by SDSPAGE.
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Immunohistochemistry was performed on adult male and female nematodes as
well as first and third-stage larvae for detection of Pt-API-1. The adults, as well as a slug
containing third-stage larvae, were embedded in tissue freezing medium. First-stage
larvae were extracted from feces and embedded in tissue freezing medium within
glycerin capsules. Cross-sections were treated with rat anti-rPt-API-1 that detected the
native antigen in the gonad, muscle, and on the cuticle of the adult organisms. The native
protein was also detected within internal structures of third and first-stage larvae. The
large presence observed in female gonads implicated release during egg-laying and
presence on the cuticle could account for the excretory-secretory component of the
protein.
Continued experimentation included PCR on adult, third-stage, and first-stage P.
tenuis using primers for Pt-api-1 and a ubiquitous gene from heat shock protein-70 (HSP70). Transcription for both genes was confirmed in all organisms further demonstrating
the presence of this protein in each examined life-stage.
Red deer were experimentally infected with either ten or twenty-five infective
third-stage larvae. ELISAs performed on sera from the deer detected infected animals
twenty-eight to fifty-six days post inoculation. At necropsy, P. tenuis adults were
recovered from eleven of the twelve infected red deer. During the experiment, patent
periods in red deer were observed with detection of L1 larvae in fecal samples. In
animals that expressed patent periods, antibodies to Pt-API-1 persisted for up to two
years. However, patent periods had no correlation with level of antibody response, nor
did degree of exposure. Secondary inoculations with equivalent doses were given at
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various intervals, but none of these secondary inoculations yielded reestablishment of
infection, suggesting an acquired immunity in red deer.

Aspartyl Protease Inhibitors in Other Parasites
Protease inhibitors are utilized by a variety of helminths to survive within the
host. Specifically, aspartyl protease inhibitors have been identified in A. suum (Martzen,
McMullen et al. 1990), O. ostertagi (De Maere, Vercauteren et al. 2005), T.
columbriformis (Shaw, McNeill et al. 2003), O. volvulus (Chandrashekar, Ogunrinade et
al. 1993), D. immitis (Hong, Mejia et al. 1996), P. tenuis (Duffy, MacAfee et al. 2002), A.
viteae (Willenbucher, Hofle et al. 1993), B. malayi (Dissanayake, Xu et al. 1993), A.
caninum (Delaney, Williamson et al. 2005), and H. contortus (Li, Gadahi et al. 2017).
As Duffy, MacAfee et al. (2002) acknowledged, these aspartyl protease inhibitors
are highly immunogenic proteins in several other previously studied nematode species,
namely B. malayi, O. volvulus, and Dirofilaria immitis. Antibodies against Bm33 of B.
malayi were observed in infected-patients (Dissanayake, Xu et al. 1993). Similarly,
Tume, Ngu et al. (1997) used sera from four-hundred forty-one patients to test the
efficacy of the aspartyl protease inhibitor Ov33 from O. volvulus in diagnostics. Using
two recombinant proteins, the combined sensitivity of the assay was 94%. Using the
same protein, Lucius, Erondu et al. (1988) found similar results with sera from 96% of
patients with onchocerciasis recognizing this antigen, but not similar antigens from B.
malayi or D. immitis. Another Ov33 homologue, DiT33, from D. immitis was used to
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detect antibodies in infected dogs and cats (Mejia, Nkenfou et al. 1994, Hong, Mejia et al.
1996).
De Maere, Vercauteren et al. (2002) identified protective antigens of O. ostertagi
with antibody probes from calves immunized with multiple infections and from primary
infected animals. western blots of extracts and excretion-secretion material from thirdstage, fourth-stage, and adult parasites to identify antigens that were recognized by the
screening antibodies. One of the antigens identified was a 28-kD aspartyl protease
inhibitor that was exclusively recognized by the antibodies from the immunized calves.
In a later study, the antigen was shown to share an 82% homology to a T. colubriformis
aspartyl protease inhibitor. It was also shown that this protein was expressed in all lifestages in western blots and RT-PCR (De Maere, Vercauteren et al. 2005).
Due to their proven immunogenicity in a variety of helminths, aspartyl protease
inhibitors are an excellent target for serological diagnosis. However, this does raise
concerns about cross reactivity between nematodes. While some research has been done
to address these cross-reactivities, there is still some room for investigation. If it were to
be used in P. tenuis diagnostics, the antigen would need to be distinct from other
common nematodes.
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CHAPTER THREE
MATERIALS AND METHODS
Production of the Pt-API-1 Protein
The P. tenuis aspartyl protease inhibitor (Pt-API-1) gene was optimized for codon
usage in E. coli and produced as a synthetic gene. The Pt-API-1 gene was cloned into an
expression vector and Pt-API-1 protein was expressed in BL21 (DE3) competent E. coli
grown in LB ampicillin broth. Protein expression was induced with Isopropyl β-D-1thiogalactopyranoside (IPTG). Cells from overnight culture were harvested by
centrifugation at 10,000g for 15 minutes at 4°C. Protein was extracted using bug buster
extraction reagent and protease inhibitor was added to ensure protein integrity. After a
20-minute incubation period, insoluble debris was removed by centrifugation at 10,000g
for 30 minutes at 4°C and supernatant was loaded onto resin for polyhistidine-tagged
purification. Three elutions were taken and Bradford assay was performed to assess level
of protein in the elutions.

Western Blot Diagnosis
In 2015, western blots were utilized to identify the presence of anti-P. tenuis API
antibody in the sera of known infected or uninfected deer. Eluted protein was run on
SDS-PAGE where it could be identified in Coomassie Blue or western immunoblots as
the band between the 28 and 38 kD marker as indicated by Duffy et.al. The protein from
the polyacrylamide gel was transferred to nitrocellulose membrane via the wet blot
technique. The membrane was cut into strips and then individually treated with primary
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antibody in the form of sera of both known infected and uninfected cervids. It was then
treated with HRP conjugated anti-cervid secondary antibody produced in chickens.
Visualization of the bands was achieved with 4-chloro-1-naphthol which produces an
insoluble purple product. The presence of a band at the 28-38 kD region indicated the
presence or absence of anti-P. tenuis antibodies present in the selected sera. This test was
successful enough to warrant tentative diagnostics to be run on elk sera collected from
Maine, New York, Minnesota, Pennsylvania, New Hampshire, and Tennessee where they
already suspected P. tenuis.

Testing with Synthetic Overlapping Peptides
Enzyme linked immunosorbent assay (ELISA) was utilized to test overlapping
10-mer synthetic peptides to further identify unique epitopes of the API protein. We used
known positive and negative serum samples which were confirmed by Western Blot to
compare potential points of cross-reactivity along the antigen. This test also used the
same enzyme conjugated anti-cervid antibody as a secondary antibody. 3,3’,5,5’tetramethylbenzidine (TMB) substrate followed by a stop solution of 0.18 molar sulfuric
acid (H2SO4) was utilized to quantify antibody concentration via optical density.
The first set of peptides tested covered the entire Pt-API-1 protein and consisted
of 29 overlapping sequences. All peptides were probed with positive sera to identify
peptides that represented epitopes with high immunogenicity. These identified peptides
were further analyzed and probed with negative sera to assess potential for false
positives.
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An additional set of peptides was subsequently used in an attempt to improve the
quality of the assay. These new peptides (1-21) were overlapping peptides of an epitope
of interest from the P. tenuis API protein identified previously. Peptides 1 and 13 were
excluded from the plate due to size constraints and had been previously identified as not
useful. The overlapping nature of these peptides also made such exclusions
inconsequential. Peptides 22, 23, and 24 from this same group were from O. ostertagi,
D. viviparus, and H. contortus respectively and represented the sequence of amino acids
found in the same epitope of those species. These were expected to be antigenically
similar to our P. tenuis protein and therefore were included to assess cross-reactivity.
To further assess cross-reactivity and false positives, sera from a negative sample
that consistently gave false positives on Western Blot and previous ELISAs was
pretreated with peptides 22, 23, and 24 separately to investigate whether pretreatment
with cross-reactive antigens would be effective at absorbing cross reactive antibodies to
improve the specificity of the test. The pretreated serum was then coated on plates of
peptides that had been shown to have the highest incidence of cross-reactivity (peptides
4, 5, and 6).
To confirm that reactions were not simply instances of antibodies binding to the
plates themselves, a dot blot was performed on nitrocellulose membrane separated into a
6x8 grid. All 24 peptides were dotted on the membrane and allowed to dry. The
remaining 24 grid squares were treated directly with positive serum samples (see Figure
3.1). The blot was blocked for 30 minutes in PBS-Tween and then incubated with a
1:100 dilution of all positive banked sera samples (1-25) for 30 minutes. It was washed
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three times with PBS-Tween for 5 minutes each before treatment with 1:500 dilution of
chicken anti-cervid HRP secondary antibody. It was washed again three times and, as
before, treated with 4-chloro-1-napthol.

Genomic Analysis for Investigation of Novel Antigens
Full genomic sequencing was done on P. tenuis adult worms harvested from dead
white-tailed deer from a hunter check station in Oak Ridge, Tennessee. DNA
purification was achieved with the MasterPure DNA Purification kit. A Nextera DNA
Library Prep kit was then used to prepare the samples for sequencing after quality was
ensured on a bioanalyzer. In lieu of the Zymo cleanup step, we used a Min-Elute PCR
Purification kit for cleanup of tagmented DNA. The libraries were sent to the UT
Genomics Core Facility for sequencing using Illumina technology and are presently
being analyzed. Parasitic nematode antigens have already been identified and will be
used for further investigation of unique antigen epitopes.
In addition to DNA, RNA libraries were also prepared. Nematodes were
harvested from the brains of dead white-tailed deer from the same hunter check station
and stored in RNA later at -20° C. The RNA was purified using the MasterPure RNA
Purification kit and then the library was prepared using the Illumina Tru-seq RNA-seq
protocol.
Sequencing was performed on an Illumina MiSeq at the University of Tennessee
Genomics Core. It was loaded at 6 picomolar with 5% 6 picomolar phiX on a version 3
flow cell reading 250 bases, paired end.
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Blast2Go software was then used to further identify proteins from transcriptomic
data (Gotz et al, 2008). Results came from running a BLASTx that utilized a public
NCBI Blast service (QBlast). The nematode (taxa: 6231, Nematoda) taxonomy filter was
used to increase the speed of results obtained and limit useless matches. The BLAST
expectation value was set at 1.0E-3 which was the default statistical significance
threshold. InterPro analysis was performed using Cloud IPS databases to further aid in
identification of proteins. Mapping and annotation were also utilized for completeness
and further descriptions to help deduce the function of hypothetical proteins.
Further investigation of transcriptome was performed using the KEGG Orthology
and Links Annotation (KOALA) service (Kanehisa, M et al, 2016). A BlastKOALA was
performed on 892 sequences that were able to be translated in Blast2Go. The taxonomy
filter for nematodes was applied to the search. Of these sequences, 518 entries (58.1%)
were annotated and grouped into functional categories. Additionally, a GhostKOALA
job was also performed resulting in 540 (60.5%) annotations. This provided statistics
that indicated taxonomic category for the sequences.

P. tenuis Protein Extraction and Biotinylation of IgG from Sera
P. tenuis organisms were digested in RIPA buffer and extracted protein was
measured using BCA assay. Approximately 7 organisms were digested to obtain enough
material for sufficient protein from the extraction.
To identify which of the proteins are interacting with IgG of infected animals,
isolation of IgG from banked known positive samples was performed using a 1 mL
NAbTM Spin Kit. Three elutions were collected from this protocol. Buffer was
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exchanged for PBS in each elution using a 100,000 MWCO Millipore ultrafiltration
column for downstream applications. After purification and buffer exchange, a UV
spectroscopy and a BCA assay were performed to assess concentration of antibodies in
the elutions and determine the amount of biotin needed for successful biotinylation.
The antibodies were biotinylated using the protocol from the EZ-Link SulfoNHS-LC-Biotin kit with 20 molar excess of biotin to antibody. Excess biotin was
removed using a 10,000 MWCO column using a pool of all three elutions. The
concentrations were analyzed using spectroscopy to ensure appropriate levels have been
maintained for downstream applications.
To assess if biotinylation was successful, ELISA on an avidin plate was
performed (See Figure 3.2). Biotinylated antibody was used to coat 24 wells and another
24 wells were treated with PBS to serve as a blank. The plate was incubated at 37° C for
1 hour, washed, and then half of the PBS wells and half of the biotinylated antibody wells
were treated with a secondary antibody which was chicken anti-cervid antibodies
conjugated with horseradish peroxidase. The cells were incubated again for 1 hour at 37°
C. After the plates were washed they were treated with TMB substrate, allowed to
incubate at room temperature for 30 minutes and then the reaction was stopped using
0.18 molar sulfuric acid. The plates were read at 450 nm.
About 1.84 mg of biotinylated antibodies were then conjugated with 0.18 mg of
extracted proteins and then passed over an avidin column for purification. Elutions
collected were sent to the University of Georgia for identification of bound proteins using

24

liquid chromatography and mass spectrometry at their Proteomics and Mass
Spectrometry Core Facility.
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CHAPTER FOUR
RESULTS AND DISCUSSION
Production of the Pt-API-1 Protein
After cloning, the vector plasmid containing a Pt-API-1 insert was purified using
the GeneJET Plasmid Miniprep Kit and yielded elevated levels of plasmid which could
then be used to transform BL21 (DE3) E. coli.
Only the first elution during polyhistidine-tagged purification was ever suitable
for use in downstream assays. Protein was confirmed with Western blot using anti-His
secondary antibody and electrochemiluminescence (ECL) to visualize the bands.

Western Blot Diagnosis
The Western Blot Diagnosis of sera from animals with known infection status
gave us a sensitivity of 0.96 and specificity of 0.78. This was significant enough for us to
go on with tentative diagnostics of unknown sera if used in conjunction with clinical
signs or positive necropsy.
However, the nature of the Western Blot itself, often left diagnosis in a gray area.
It was easy to misinterpret a faint line as a negative and human nature tended to err on the
side of diagnosing false positives. This was compounded by the issue of some known
negatives testing as strong positives which was thought to be due to cross reactivity of
similar parasites.
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This prompted further investigation using the 10-mer synthetic overlapping
peptides to identify regions of the antigen that were reacting with negative sera
antibodies.

Testing with Synthetic Overlapping Peptides
Results obtained from the ELISAs with whole antigen overlapping peptide
revealed several epitopes when probed with positive sera (See Figure 4.1). When
compared with negative sera, however, it was evident that many of these epitopes were
also reactive with antibodies from animals known not to be infected (See Figure 4.2). It
was determined that the epitopes found in peptides 5-7 were promising enough to warrant
designing more overlapping peptides focusing in that region. This would allow us to
obtain higher quality peptides as well, hopefully solving some of the repeatability issues
that had arose.
Results obtained from the ELISAs with the overlapping peptides at the previously
identified epitope suggest reactive regions around peptides 15-21. Overall, the results
suggest that there is significant cross-reactivity with similar parasites such as O.
ostertagi, D. viviparus, and H. contortus. This is seen by the negative sample, N14-447
consistently reacting with these 3 peptides as well as having high reactivity with the P.
tenuis antigen at peptides 4, 5, and 6 (see Figure 4.3).
The pretreatment of negative sera (N14- 423) and positive sera (PT+ 1 and PT+
13) with peptides 22, 23, and 24 was not effective at eliminating the incidence of false
positives. As seen in Figure 4.2, there was not a significant drop in the negative sample’s
reactivity after pretreatment and it still was showing consistently high results.
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Furthermore, the positive samples also seemed to react with the antigen treatment,
resulting in an unwanted decrease of their reactivity. This supports our theory of similar
parasites inducing false positives in animals lacking any history of P. tenuis infection.
A dot blot confirmed the results obtained by the ELISAs. Peptides 5, 12, 13, 14,
15, 17, 22, and 24 were all reactive to banked positive sera (see Figure 4.5).
Unfortunately, the reactivity with peptides 22 and 24 further emphasize the degree of
cross reactivity with similar parasites.

Genomic Analysis for Investigation of Novel Antigens
DNA analysis showed that much of the sequenced data was deer DNA. The DNA
was high quality, but with short reads and not many open reading frames. However,
there were some sequences found that were identified as parasitic nematode antigens.
The RNA analysis proved to be much better with over 1000 transcripts and
numerous open reading frames. It was also possible to perform in silico subtraction of
the deer genome, making it much cleaner than the DNA results. Our BLAST results have
already shown numerous unique proteins and 70 of the 1118 had no result at all in the
database. As expected, many of these proposed proteins are hypothetical (not annotated)
as genomes from this and similar parasites have not been reported. Top matches for the
entire genome included parasites such as D. viviparus, H. contortus, and Ancylostoma
spp. (See Figure 4.6).
The previously investigated aspartyl protease inhibitor was also sequenced in this
transcriptome. BLAST results showed similarities of other nematode aspartyl protease
inhibitors such as Angiostrongylus cantnensis (89.4%), Dictyocaulus vivparus (85.8%),
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Trichostrongylus colubriformis (79.5%), Ancylostoma duodenale (84.0%), Haemonchus
contortus (84.5 %), Necator americanus (87.8%), and Ostertagia ostertagi (86.7%).
The incomplete nature of all accessible databases makes significant identification
of antigens difficult. BlastKOALA was arguably the most appropriate tool to obtain an
overview of the functionality of the proteins discovered as it is used to annotate highquality genomes. Of the 892 entries submitted, 518 were annotated (58.2%). Genetic
information processing comprised around 45.69% of the entries annotated. Carbohydrate
metabolism, energy metabolism, and environmental information processing comprised
8.1%, 7.9%, and 6.8% respectively (See Figure 4.7a). A GhostKOALA search was also
performed despite our transcriptome being higher quality than a metagenome usually
used in these searches. This was done because it was known that databases for
nematodes are incomplete and GhostKOALA obtained a taxonomic breakdown of the
data that could indicate the percentage of annotations that were correctly attributed to
nematodes. The GhostKOALA came back with 540 (60.5%) annotations, roughly given
the same functional category distribution as the more precise BlastKOALA search.
Interestingly, 734 of the 892 sequences (82.3%) were correctly identified as nematodes.
This left 149 (16.7%) undefined. The remaining <2% were Vertebrates, arthropods,
eudicots, and basidiomycetes (See Figure 4.7b). It is assumed that many of those
misidentified and undefined are the result of the incomplete nematode databases available
or due to poor quality transcripts.
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P. tenuis Protein Extraction and Biotinylation of IgG from Sera
An estimated 0.339 mg of protein was extracted from P. tenuis organisms when
analyzed by BCA assay. Antibody elutions E1, E2, and E3 measured at 280 nm were
4.5, 4.60, and 3.01 mg respectively but after buffer exchange were significantly reduced
to 1.3, 0.9, and 0.2 mg. This loss has been seen before using these columns and while
frustrating, there was still plenty to use for downstream applications.
After biotinylation, a BCA assay using bovine serum albumin (BSA) as a
standard revealed E1, E2, and E3 to be 1.73, 1.19, and 0.08 mg. The spectrometer read
E1 as 3.35 mg, so it was assumed that the real concentration fell somewhere between
1.73 and 3.35 mg. The BSA standard likely does not react identically with the BCA
assay as the protein of interest. Factors such as hydrophobicity and amino acid
composition can influence color reaction outside of protein concentration (Wiechelman et
al., 1988). Spectrometry, on the other hand, measures the concentration by detecting
aromatic residues and does not require comparison to a standard curve.
Excess biotin was removed using a smaller 10,000 MWCO column in an attempt
to reduce loss. Final concentrations for E1, E2, and E3 after removal of excess biotin in
PBS measured 1.28, 0.56, and 0.11 mg respectively.
After biotinylation was confirmed, E1 and E2 were combined to achieve
approximately 1.84 mg of antibody which was then incubated with 0.18 mg of the
acquired protein at 37° C for 1 hour. Excess antibody to extracted P. tenuis protein
should help with maximum binding of all possible antigens. After passing through the
avidin column, the best elutions were found to be B2 and B3 (1.0 and 0.4 mg
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respectively). These samples were sent to the University of Georgia for identification of
bound proteins using liquid chromatography and mass spectrometry at their Proteomics
and Mass Spectrometry Core Facility.
At present, results are pending, but several proteins have been identified from the
data. An SCP-like extracellular protein has shown significant promise and shares
minimal homology with similar nematodes. Its closest identity was 45% with
Ancylostoma ceylancium, a type of hookworm. A synthetic gene for this protein has been
created and efforts are underway to investigate its efficacy in diagnostic testing.
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CHAPTER FIVE
CONCLUSIONS AND RECOMMENDATIONS
Inability to Quantitively Diagnose Populations
The ability to assess prevalence, even in white-tailed deer populations, leaves
much to be desired. The possibility of unisex infections increases the likelihood of
obtaining false negatives during fecal exams (Slomke, Lankester et al. 1995).
Additionally, the skill required during necropsy also will leave some misdiagnosed. If
the person performing the necropsy fails to thoroughly open the venus sinuses along the
meninges, many worms can go unnoticed.
This leaves us with many issues. Primarily, we are unable to accurately predict
rate of infection or even infection status accurately. This information would be
invaluable while creating an antemortem serological assay as we could obtain sera from a
random selection of white-tailed deer and compare our observed prevalence in the sera to
the known prevalence of the given area with a chi square test. With things how they are,
however, this is impossible to do with any amount of accuracy.
Once a reliable serological diagnostic is acquired, we will have the ability to test
collections of banked sera and perform retrospective studies on P. tenuis prevalence over
time. This could provide insight on the rate that the parasite has spread across
populations that presently impossible to assess.
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Experimental Infections
Model organisms have been used in the past to aid with P. tenuis serological
diagnosis. Immunized rats have been proven to produce antibodies against P. tenuis that
can be detected and reliably diagnosed (Duffy, MacAfee et al. 2002).
Incorporation of model organisms in future research after another novel antigen
would be useful. Mice and rats would be the logical starting point for such investigation,
but further experimentation could even incorporate guinea pigs which have been shown
to become naturally infected (Southard, Bender et al. 2013).

Cross Reactivity is a Significant and Underdiscussed Issue
Cross reactivity was a significant issue during this study and something that has
been previously underdiscussed. O. ostertagi was previously found to have 74%
sequence identity with the Pt-API-1 gene, however, in that same study, it was not
determined whether exposure to O. ostertagi would produce a false positive (Duffy,
MacAfee et al. 2002). From our own BLAST results, O. ostertagi, had 86.7% similarity
with P. tenuis which could easily explain the cross reactivity.
When positive sera were pre-treated with O. ostertagi, D. viviparus, and H.
contortus antigen, there was an overall decrease in binding to P. tenuis antigen,
suggesting that the antibodies created against P. tenuis also had significant interactions
with the aspartyl-protease inhibitors of these similar parasites (Fig. 4.2).
Further work needs to be done to identify an antigen that does not possess this
degree of cross-reactivity. So far, we have compiled a transcriptome for P. tenuis and
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have used banked positive sera to capture potential antigen targets extracted from whole
L3 adult worms. Once analysis of these antigens is completed we will be able to cross
reference them to our transcriptome and identify a gene for insertion into a plasmid
vector and protein expression in competent E. coli.

Promising Results Obtained with Elaeophora Immunogenic Antigens
Using the same antigen capture protocol we used with P. tenuis, Elaeophora
schneideri immunogenic antigens have been identified (see Figure 5.1) and are presently
undergoing testing with known positive and negative sera. As with P. tenuis, many of the
peptides identified yielded hypothetical proteins in the BLAST search due to the lack of
genomic information in the database.
A source protein for a few of the peptides was identified from this data. Using
specially designed primers, a PCR was performed to amplify the gene responsible for this
source protein and was inserted into a plasmid vector for protein expression in E. coli.
Work with this organism is also presently ongoing, but the results have indicated
similar techniques with P. tenuis should yield comparable results. Results from UGA
have identified at least one promising new target that can be cross-identified to
transcriptomic data. Presently, efforts to amplify this gene from purified P. tenuis DNA
and insertion into a plasmid vector for protein expression is ongoing. Previous issues
with insertion of an Elaeophora gene has led to the decision to construct a synthetic gene
with codon optimization for expression in E. coli.
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Competitive ELISAs
Ultimately, the diagnostic assay used to diagnose P. tenuis would employ a
competitive ELISA that is compatible with a multitude of species. This way, the test
used to diagnose alpacas would be identical to the one used to diagnose cervid species.
This is particularly important as P. tenuis infects a wide variety of aberrant hosts
including horses, goats, alpacas, moose, elk, and even guinea pigs (Southard, Bender et
al. 2013).
Commercial production of this diagnostic assay would be valuable not only to
wildlife veterinarians and biologists studying P. tenuis in cervid populations, but also a
definitive diagnostic for farm animal and companion veterinarians in the clinical setting.
Its applications could be useful for both monitoring and treating incidences of
parelaphostrongylosis.
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Table 4.1: Testing of sera with known P. tenuis status using western blot (WB). These results
revealed a sensitivity of 0.96 and specificity of 0.78.
Sample ID

Expected Result

WB Result

N14-415

Negative

Negative

N14-419

Negative

Negative

N14-423

Negative

Positive

N14-425

Negative

Negative

N14-438

Negative

Negative

N14-447

Negative

Positive

N14-450

Negative

Negative

N14-455

Negative

Negative

N14-462

Negative

Negative

N14-466

Negative

Negative

N14-467

Negative

Negative

N14-468

Negative

Positive

N14-475

Negative

Negative

N14-476

Negative

Negative

PT+1

Positive

Positive

PT+2

Positive

Positive

PT+3

Positive

Positive

PT+4

Positive

Positive

PT+5

Positive

Positive

PT+6

Positive

Positive

PT+7

Positive

Positive

PT+8

Positive

Positive

PT+9

Positive

Positive
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Table 4.1 continued
Sample ID

Expected Result

WB Result

PT+10

Positive

Positive

PT+11

Positive

Positive

PT+12

Positive

Positive

PT+13

Positive

Positive

PT+14

Positive

Positive

PT+15

Positive

Positive

PT+16

Positive

Positive

PT+17

Positive

Positive

PT+18

Positive

Positive

PT+19

Positive

Positive

PT+20

Positive

Positive

PT+21

Positive

Negative

PT+22

Positive

Positive

PT+23

Positive

Positive

PT+24

Positive

Positive

PT+25

Positive

Positive
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1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

PT+1
PT+1
undiluted 1:100

PT+1
1:200

PT+1
1:300

PT+1
1:400

PT+1
1:500

PT+1
1:600

PT+1
1:700

PT+3
PT+3
undiluted 1:100

PT+3
1:200

PT+3
1:300

PT+3
1:400

PT+3
1:500

PT+3
1:600

PT+3
1:700

PT+5
PT+5
undiluted 1:100

PT+5
1:200

PT+5
1:300

PT+5
1:400

PT+5
1:500

PT+5
1:600

PT+5
1:700

Figure 3.1: Schematic of dot blot used to assess the sera antibody reactivity to the Pt-API-1
overlapping synthetic peptides. Upper three rows were directly blotted with peptide indicated to
assess primary antibody binding to antigen. Bottom three rows were directly blotted with sera
indicated to ensure secondary antibody binding to primary antibody.
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PBS

Biotinylated Antibody

PBS

2°

E1

E1

E2

E2

E3

E3

E1

E1

E2

E2

E3

E3

E1

E1

E2

E2

E3

E3

E1

E1

E2

E2

E3

E3

Figure 3.2: Schematic of ELISA done to assess biotinylation. None of the wells on the left half of the
plate contained primary antibody (biotinylated antibody). Upper left-hand corner wells were PBS
blanks with lower left-hand serving as a secondary antibody control. All wells on the right half of the
plate contained primary antibody (elution of biotinylated antibody as depicted) so that each iteration
had quadruplicates. Primary and secondary antibody together were only in the lower right-hand
corner of the plate.
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Pt-API- 1 Overlapping Peptides (Positive Sera)
1.6

Relative Optical Density

1.4
1.2
1
0.8
0.6
0.4
0.2
0
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Peptide Number
Figure 4.1: Epitopes identified using synthetic overlapping peptides of the whole antigen and known
positive sera. Results indicate peaks around peptides 5, 14, 15, and 20. These suggest potential
epitopes on the protein.
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Peptide 13-23
2.5

2

1.5

1

0.5

0
Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide Peptide
13
14
15
16
17
18
19
20
21
22
23
N14 447

PT+4

PT+5

PT+24

Figure 4.2: Comparison of negative sera reactivity (N14-447) and positive sera (PT+4, PT+5, PT+24)
shows significant reactivity despite infection status being negative. Particularly, peptides 14 and 18
feature negative sera reacting stronger than all positive samples.
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Peptides 2-12 & 14-24
RELATIVE OD

4
3
2
1
0

2
3
4
5
6
7
8
9
10
11
12
14
15
16
17
18
19
20
21
22
23
N14-447 2.054 1.301 2.303 2.236 2.832 2.418 2.594 3.015 3.26 2.927 2.793 3.219 2.677 2.508 2.415 2.28 2.264 2.313 2.448 2.748 2.447

24
2

P+1

2.067 1.305 2.045 2.011 2.219 2.189 2.227 2.22 2.297 2.317 2.215 2.012 1.94 2.021 1.944 1.895 2.064 1.981 1.948 1.793 1.751 0.824

P+3

1.811 1.295 1.764 1.77 1.931 1.828 1.831 1.831 1.918 1.985 1.943 1.703 1.695 1.602 1.63 1.459

P+5

2.782 2.091 2.599 2.711 2.766 2.65 2.663 2.421 2.848 2.954 2.833 2.601 2.612 2.612 2.531 2.586 2.517 2.594 2.619 2.546 2.477 1.41

1.7

1.751 1.663 1.618 1.582 0.771

Figure 4.3: Testing sera reactivity across overlapping Pt-API-1peptides (2-21) and peptides of similar
antigenically similar parasites (22-24). Peptide 22 is O. ostertagia, peptide 23 is D. viviparus, and
peptide 24 is H. contortus. These result an area of interest around peptides 15-21, but also show
significant cross-reactivity with antigens of similar parasites.
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Serum Treated with Peptides of Similar Parasites
4
3
2
1
0
N14 423 PT+ 1
None

PT+ 13 N14 423 PT+ 1

PT+ 13 N14 423 PT+ 1

O. ostertagi
Peptide 4

PT+ 13 N14 423 PT+ 1

D. viviparus
Peptide 5

PT+ 13

H. contortus

Peptide 6

Figure 4.4: Testing sera pre-treated with peptides of similar parasites to attempt and reduce cross
reactivity. Results show that regardless of pretreatment, cross reactive antibodies are not adequately
absorbed by similar parasite peptides to reduce incidences of false positives.
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Figure 4.5: Dot blot performed with peptides 1-24 to assess positive sera binding to peptides.
Peptides 3, 5, 12, 13, 14, 15, 16, 17, 22, and 24 all reacted with the pooled positive sera. The bottom
three rows were blotted directly with serial dilutions of three selected sera to ensure the secondary
antibody would bind to the serum antibodies.
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Figure 4.6: Top BLAST hits feature parasites seen to have cross reactivity with our antigen such as
D. viviparus and Haemonchus contortus. Absence of O. ostertagia in this constructed graph is
probably due to an insufficient database.
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Figure 4.7: KEGG Orthology and Links Annotation results. BlastKOALA (A) returned 518 entries
(58.1%) annotated into functional categoreis. GhostKOALA returned 540 entires (60.5%) annotated
into functional categories with the majority falling under the nematode taxxonomic category.
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Figure 5.1: Immunogenic peptides found in Elaeophora schneideri after antigen capture with
positive sera.
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